PURPOSE: To investigate and compare the relative efficacy, recurrence and complications of endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) for the treatment of @entity6312 @entity1 . METHODS: Searches were applied to the Cochrane Library as well as MEDLINE, EMBASE, BIOSIS databases. 12 articles published in English (10 randomized controlled trials and 2 cohort study) were identified from specialized trails. Fixed effect model and Random effect model were applied to compare the vein ablated length, @entity158 scores (3days and 10days), quality of Life, occlusion, over all complication, @entity2268 , haematoma and recanalization between the EVLA and RFA group. The results were expressed as odds ratio (OR) or relative risk (RR) and 95% confidence intervals (CI) for categorical outcomes. RESULTS: 12 reported studies with a combined total of 1577 @entity1 were included. vein ablated length ( @entity7126 :0.37, 95%CI: 0.04 to 0.77), 3days @entity158 scores ( @entity7126 :11.25, 95%CI: 3.42 to 25.92) and 10days ( @entity7126 :0.79,95%CI: 0.48 to 2.05),1 month quality of Life ( @entity7126 : 0.09,95%CI: 0.28 to 0.10) and 1 year ( @entity7126 : 0.04,95%CI: 0.21 to 0.13), occlusion (OR:1.05,95%CI:0.41 to 2.73), @entity2268 (RR:1.03,95%CI:0.56 to 1.92), haematoma (OR:1.55, 95%CI:0.54 to 4.45) and recanalization (OR:0.68,95%CI:0.43 to 1.09) following RFA showed no difference when compared with EVLA. These results were not statistically significant. RFA was associated with the lower overall complication (OR: 3.49, 95%CI:1.36 to 8.96) in @entity1 with @entity6312 compared to the EVLA treatment. CONCLUSION: EVLA and RFA seem to be the same safe and effective on clinical efficacy (vein ablated length, 3days and 10days @entity158 scores, 1 month and 1 year quality of life, occlusion, @entity2268 , haematoma and recanalization). Data on RFA seems to having potential benefits from reducing risk of overall complication than EVLA, which is needed by large high-quality prospective randomized trials.

Comparison of ultrasound-guided endovenous laser ablation and radiofrequency for the XXXX treatment: An updated meta-analysis.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity7126 :: ('MESH:C537501', 'Disease') :: ['SMD'] @entity2268 :: ('MESH:D013924', 'Disease') :: ['thrombophlebitis'] @entity6312 :: ('MESH:D014648', 'Disease') :: ['varicose veins'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain']
@entity6312 :: (MESH:D014648,Disease) :: ['varicose veins']
